| Literature DB >> 34885792 |
Kolade Olatubosun Faloye1, Boris Davy Bekono2,3, Emmanuel Gabriel Fakola1, Marcus Durojaye Ayoola4, Oyenike Idayat Bello4, Oluwabukunmi Grace Olajubutu5, Onikepe Deborah Owoseeni4, Shafi Mahmud6, Mohammed Alqarni7, Ahmed Abdullah Al Awadh8, Mohammed Merae Alshahrani8, Ahmad J Obaidullah9,10.
Abstract
Glucokinase activators are considered as new therapeutic arsenals that bind to the allosteric activator sites of glucokinase enzymes, thereby maximizing its catalytic rate and increasing its affinity to glucose. This study was designed to identify potent glucokinase activators from prenylated flavonoids isolated from medicinal plants using molecular docking, molecular dynamics simulation, density functional theory, and ADMET analysis. Virtual screening was carried out on glucokinase enzymes using 221 naturally occurring prenylated flavonoids, followed by molecular dynamics simulation (100 ns), density functional theory (B3LYP model), and ADMET (admeSar 2 online server) studies. The result obtained from the virtual screening with the glucokinase revealed arcommunol B (-10.1 kcal/mol), kuwanon S (-9.6 kcal/mol), manuifolin H (-9.5 kcal/mol), and kuwanon F (-9.4 kcal/mol) as the top-ranked molecules. Additionally, the molecular dynamics simulation and MM/GBSA calculations showed that the hit molecules were stable at the active site of the glucokinase enzyme. Furthermore, the DFT and ADMET studies revealed the hit molecules as potential glucokinase activators and drug-like candidates. Our findings suggested further evaluation of the top-ranked prenylated flavonoids for their in vitro and in vivo glucokinase activating potentials.Entities:
Keywords: ADMET; density functional theory; glucokinase activators; molecular docking; molecular dynamics simulation; prenylated flavonoids
Mesh:
Substances:
Year: 2021 PMID: 34885792 PMCID: PMC8659159 DOI: 10.3390/molecules26237211
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Conformation of native ligand (yellow) and re-docked ligand (blue) showing similar poses in the active site of glucokinase enzyme.
Interaction analysis of arcommunol B, kuwanon S, manuifolin H and kuwanon F with the glucokinase enzyme.
| Ligand | Chemical Structure | Binding Energy (kcal/mol) | Hydrogen Bonding Interaction | Hydrophobic Interaction | Pi-Interaction | |
|---|---|---|---|---|---|---|
| Amino Acid Residue | Distance (Å) | |||||
| Arcommunol B |
| −10.1 | Tyr61 | 2.19 | Val62, Arg63, Pro66, Ile159, Ile211, Tyr214, Val452, Val455, | Val62, Arg63, Pro66, Ile159, Ile211, Tyr214, Met235, Val452, Val455 |
| Kuwanon S |
| −9.6 | - | - | Val62, Arg63, Pro66, Ile211, Tyr214, Val452, Val455, Ala456, Lys458, Lys459, | Val62, Arg63, Pro66, Ile211, Tyr214, Val452, Val455, Ala456, Lys458, Lys459. |
| Manuifolin H |
| −9.5 | Leu451 | 2.05 | Val62, Arg63, Pro66, Ile211, Tyr214, Met235, Val452, Val455, | Val62, Arg63, Pro66, Ile211, Tyr214, Met235, Val452, Val455. |
| Kuwanon F |
| −9.4 | Val452 | 2.82 | Val62, Arg63, Pro66, Ile159, Ile211, Tyr214, Val452, Val455, | Val62, Arg63, Pro66, Ile211, Tyr214, Val452, Val455 |
Figure 2Interaction diagram of arcommunol B (a), kuwanon S (b), manuifolin H (c), and kuwanon S (d) with glucokinase enzyme.
Figure 3Molecular dynamics trajectory analysis of arcommunol B −1V4S: (a) RMSD of protein-ligand complex, (b) RMSF of protein-ligand complex, and (c) histogram of protein-ligand contacts.
Figure 4Molecular dynamics trajectory analysis of Kuwanon S−1V4S: (a) RMSD of protein-ligand complex, (b) RMSF of protein-ligand complex, and (c) histogram of protein-ligand contacts.
Figure 5Molecular dynamics trajectory analysis of manuifolin H−1V4S: (a) RMSD of protein-ligand complex, (b) RMSF of protein-ligand complex, and (c) histogram of protein-ligand contacts.
Figure 6Molecular dynamics trajectory analysis of kuwanon F−1V4S: (a) RMSD of protein-ligand complex, (b) RMSF of protein-ligand complex, and (c) histogram of protein-ligand contacts.
MMGBSA ΔG binding scores of the top-ranked molecules.
| Ligand | MMGBSA ΔG Bind | MMGBSA ΔG Bind Coulomb | MMGBSA ΔG Bind Covalent | MMGBSA ΔG Bind Solvation Energy | MMGBSA ΔG Bind vdW |
|---|---|---|---|---|---|
| Arcommunol B | −70.23 | −5.27 | 1.63 | 21.11 | −57.91 |
| Kuwanon S | −54.86 | −9.12 | 2.23 | 17.20 | −50.88 |
| Manuifolin H | −37.34 | −7.26 | 1.35 | 15.94 | −29.89 |
| Kuwanon F | −26.76 | −8.64 | 0.97 | 14.48 | −27.12 |
Some calculated quantum chemical parameters for the compounds.
| Ligands | EHOMO | ELUMO | ΔE | η (Chemical Hardness) | μ (Chemical Potential) | ω (Electrophilcity Index) |
|---|---|---|---|---|---|---|
| Arcommunol B | −5.70 | −1.30 | 4.40 | 2.20 | −3.5 | 2.78 |
| Kuwanon S | −5.83 | −1.68 | 4.15 | 2.08 | −3.76 | 3.40 |
| Manuifolin H | −5.19 | −0.01 | 5.18 | 2.59 | −2.60 | 1.31 |
| Kuwanon F | −5.43 | −1.31 | 4.12 | 2.06 | −3.37 | 2.76 |
Figure 7(A) Illustration of HOMO and LUMO of Arcommunol B and Kuwanon S. (B) Illustration of HOMO and LUMO of Manuifolin H and Kuwanon F.
Pharmacokinetics and drug-likeness studies of arcommunol B, kuwanon S, manuifolin H, and kuwanon F.
| Ligands | Lipinski Rule Violation | Veber Rule Violation | PAINS Test | Solubility | BBB | HIA | Acute Oral Toxicity | Carcinogenicity |
|---|---|---|---|---|---|---|---|---|
| Arcommunol B | 0 | 0 | 0 | −4.700 | + | + | 2.347 | - |
| Kuwanon F | 0 | 0 | 0 | −4.078 | + | + | 2.612 | - |
| Kuwanon S | 0 | 0 | 0 | −4.351 | + | + | 2.208 | - |
| Manuifolin H | 0 | 0 | 0 | −3.392 | + | + | 1.8 | - |
Figure 8MESP of (a) Arcommunol B, (b) Kuwanon S, (c) Manuifolin H, and (d) and Kuwanon F.
Enzyme and the amino acid residues at its binding site.
| PDB ID | Residues within 5 Å | Native Ligand |
|---|---|---|
| 1V4S | Tyr61, Val62, Arg63, Ser64, Thr65, Pro66, Gln98, Ile159, Met210, Ile211, Tyr214, Tyr215, His218, Cys220, Glu221, Met235, Arg250, Leu451, Val452, Val455, Ala456 | 2-Amino−4-fluoro−5-[(1-methyl−1H-imidazol−2-yl)sulfanyl]-N-(1,3-thiazol−2-yl)benzamide |